M/s. OOO Jodas Expoim.. Pharmaceutical Import Profile — Russia (DGFT 2022–2026)

Name: M/s. OOO Jodas Expoim.. Pharmaceutical Import Records from India — 3 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. OOO Jodas Expoim.. — Pharmaceutical Importer Profile (2026) | 3 Products, $1.1M Trade | TransData Nexus

M/s. OOO Jodas Expoim..

Pharmaceutical Importer · Russia · Cardiovascular Focus · $1.1M Total Trade · DGFT Verified

M/s. OOO Jodas Expoim.. is a pharmaceutical importer based in Russia with a total trade value of $1.1M across 3 products in 3 therapeutic categories. Based on 21 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/s. OOO Jodas Expoim.. sources from 1 verified Indian supplier, with Jodas Expoim Private Limited accounting for 100.0% of imports.

M/s. OOO Jodas Expoim.. — Import Portfolio & Supplier Network

M/s. OOO Jodas Expoim.. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. OOO Jodas Expoim..?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Jodas Expoim Private Limited	$2.2M	55	100.0%

M/s. OOO Jodas Expoim.. sources from 1 verified Indian supplier across 25 distinct formulations. The sourcing is highly concentrated — Jodas Expoim Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does M/s. OOO Jodas Expoim.. Import?

Formulation	Value	Ships
Heparin sodium solution for	$850.0K	17
Acyclovir lyophilized for preparation	$250.0K	5
Omeprazole lyophilisate for	$150.0K	3
Oxaliplatin concentrate for	$100.0K	2
Paclitaxel concentrate for preparation	$100.0K	2
Tigecycline lyophilisate for	$100.0K	2
Teicoplanin lyophilisate for the	$100.0K	2
Imatinib tablets 400MG (3x10 tablets)	$50.0K	1
Ampicillin and sulbactam for injection	$50.0K	1
Gadodiamide injection USP 287MG/ML -	$50.0K	1
Aztreonam for injection USP 1	$50.0K	1
Iron [iii] hydroxide sucrose complex SOL	$50.0K	1
Fluconazole injection USP 2MG/ML-	$50.0K	1
Anastrozole tablets 1MG (3x10 tablets)	$50.0K	1
Diatrizoate meglumine and diatrizoate	$42.7K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Heparin	Cardiovascular	$850.0K	17	0.2%	13
2	Oxaliplatin	Advanced Oncology	$100.0K	2	0.2%	20
3	Teicoplanin	Advanced Antibiotics	$100.0K	2	1.6%	10

M/s. OOO Jodas Expoim.. imports 3 pharmaceutical products across 3 categories into Russia totaling $1.1M.

M/s. OOO Jodas Expoim.. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. OOO Jodas Expoim is a Russian pharmaceutical importer and distributor specializing in the procurement and distribution of finished pharmaceutical formulations. Headquartered in Voskresensk, Moscow Region, Russia, the company operates as a key player in the Russian pharmaceutical supply chain, focusing on the importation of specialized generic medicines. Notably, Jodas Expoim has been involved in the commercialization of various pharmaceutical products, including anti-infectives and oncology treatments, in the Russian market.

The company maintains a close relationship with its parent company, Jodas Expoim Pvt. Ltd., an Indian pharmaceutical manufacturer known for its specialization in generic injectables and oncology products. This affiliation underscores a strategic partnership aimed at enhancing the availability of high-quality, affordable medicines in Russia. Jodas Expoim Pvt. Ltd. operates state-of-the-art manufacturing facilities in Hyderabad, India, and has a consolidated presence in over 25 countries, including Russia.

2Distribution Network

Jodas Expoim's distribution network in Russia is strategically designed to ensure efficient delivery of pharmaceutical products across the country. The company's logistics capabilities include a centralized warehouse located in Voskresensk, Moscow Region, which serves as the primary hub for inventory management and distribution. This centralization facilitates streamlined operations and timely delivery to various regions within Russia. While specific details about additional warehouse locations or logistics infrastructure are not publicly disclosed, the company's established presence in over 25 countries suggests a robust and scalable distribution framework capable of meeting diverse market demands.

3Industry Role

In Russia's pharmaceutical supply chain, M/s. OOO Jodas Expoim functions primarily as a pharmaceutical importer and distributor. The company focuses on sourcing specialized generic medicines from its parent company, Jodas Expoim Pvt. Ltd., and other suppliers, and distributing these products to various healthcare providers, including hospitals, clinics, and pharmacies across Russia. This role positions Jodas Expoim as a critical intermediary between international pharmaceutical manufacturers and the Russian healthcare system, ensuring the availability of essential medicines to meet the country's medical needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. OOO Jodas Expoim..

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Jodas Expoim's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from Jodas Expoim Pvt. Ltd. in India. This single-source dependency indicates a strategic choice to maintain a consistent supply of specialized generic medicines, leveraging the manufacturing capabilities and product portfolio of its parent company. The shipment data reveals a stable and ongoing relationship, with 55 shipments valued at $2.2 million, accounting for 100% of the company's imports from India. This consistent sourcing pattern suggests a well-established and reliable partnership, minimizing potential supply chain disruptions.

2Supply Chain Resilience

The resilience of Jodas Expoim's supply chain is closely tied to its exclusive sourcing arrangement with Jodas Expoim Pvt. Ltd. While this concentrated sourcing strategy ensures product consistency and quality, it also presents potential risks associated with over-reliance on a single supplier. The absence of publicly available information regarding backup suppliers or alternative sourcing strategies indicates a limited diversification in the supply chain. Additionally, the company's focus on a narrow range of formulations—25 unique products across three therapeutic categories—suggests a specialized product portfolio. This specialization may limit the company's ability to adapt to sudden market changes or disruptions in the supply chain. However, the established relationship with Jodas Expoim Pvt. Ltd., a company with a consolidated presence in over 25 countries, including Russia, may provide a degree of stability and support in mitigating potential supply chain challenges.

Importing Pharmaceuticals into Russia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Russia

1Regulatory Authority & Framework

In Russia, the regulation of pharmaceutical imports is overseen by the Ministry of Health, which is responsible for ensuring the safety, efficacy, and quality of medicines entering the Russian market. Key legislation governing pharmaceutical imports includes Federal Law No. 61-FZ "On Circulation of Medicines," which outlines the requirements for the registration, importation, and distribution of pharmaceutical products. The registration process involves submitting comprehensive documentation to the Ministry of Health, including clinical trial data, manufacturing information, and quality control measures. Once registered, pharmaceutical products are subject to federal state control, which includes inspections and monitoring to ensure compliance with Russian standards. This regulatory framework aims to protect public health by ensuring that all imported medicines meet the necessary safety and quality standards.

2Import Licensing & GMP

Import licensing in Russia requires pharmaceutical companies to obtain authorization from the Ministry of Health before importing medicines. This process involves providing detailed information about the product, including its composition, manufacturing process, and intended use. Good Manufacturing Practice (GMP) certification is a critical component of the import licensing process. Russia recognizes GMP certifications from reputable international bodies, including the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Pharmaceutical companies seeking to import medicines into Russia must ensure that their manufacturing facilities hold valid GMP certifications from these recognized organizations. Additionally, companies must obtain wholesale distribution authorization, which permits them to distribute pharmaceutical products within Russia. This authorization requires compliance with specific storage, handling, and distribution standards to maintain product integrity and safety.

M/s. OOO Jodas Expoim.. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Jodas Expoim's product strategy focuses on specialized therapeutic areas, including anti-infectives, oncology, and contrast media, with a particular emphasis on injectable formulations. This focus aligns with the company's mission to provide high-quality, effective, and affordable generic medicines to meet the unmet medical needs of the Russian healthcare community. The market demand for these products is driven by the prevalence of infectious diseases, cancer, and diagnostic imaging procedures in Russia, necessitating a reliable supply of specialized pharmaceutical products. By concentrating on these therapeutic areas, Jodas Expoim aims to address critical healthcare challenges and improve patient outcomes across the country.

2Sourcing Profile

Jodas Expoim's sourcing strategy is centered on procuring generic pharmaceutical products from its parent company, Jodas Expoim Pvt. Ltd., in India. This approach leverages the manufacturing capabilities and product portfolio of Jodas Expoim Pvt. Ltd., which specializes in generic injectables and oncology products. The company's focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), indicates a preference for ready-to-market products that meet Russian regulatory standards. India's established reputation for producing high-quality generics aligns with Jodas Expoim's sourcing requirements, ensuring a consistent supply of effective and affordable medicines for the Russian market.

Frequently Asked Questions — M/s. OOO Jodas Expoim..

What products does M/s. OOO Jodas Expoim.. import from India?

M/s. OOO Jodas Expoim.. imports 3 pharmaceutical products across 3 categories. Top imports: Heparin ($850.0K), Oxaliplatin ($100.0K), Teicoplanin ($100.0K).

Who supplies pharmaceuticals to M/s. OOO Jodas Expoim.. from India?

M/s. OOO Jodas Expoim.. sources from 1 verified Indian suppliers. The primary supplier is Jodas Expoim Private Limited (100.0% of imports, $2.2M).

What is M/s. OOO Jodas Expoim..'s total pharmaceutical import value?

M/s. OOO Jodas Expoim..'s total pharmaceutical import value from India is $1.1M, based on 21 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. OOO Jodas Expoim.. focus on?

M/s. OOO Jodas Expoim.. imports across 3 categories. The largest: Cardiovascular (81.0%), Advanced Oncology (9.5%), Advanced Antibiotics (9.5%).

Get Full M/s. OOO Jodas Expoim.. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

M/s. OOO Jodas Expoim..

M/s. OOO Jodas Expoim.. — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to M/s. OOO Jodas Expoim..?

What Formulations Does M/s. OOO Jodas Expoim.. Import?

What Products Does M/s. OOO Jodas Expoim.. Import?

Top Products by Import Value

M/s. OOO Jodas Expoim.. Therapeutic Categories — 3 Specializations